Stroke: Epidemiology, clinical picture, and risk factors: Part I of III

Angiology

Volumn 51, Issue 10, 2000, Pages 793-808

  Tegos, Thomas J ^a   Kalodiki, Evi ^a   Daskalopoulou, Stella Styliani ^a   Nicolaides, Andrew N ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ARTERY DISEASE; BRAIN CIRCULATION; BRAIN HEMORRHAGE; CAROTID ARTERY; CIGARETTE SMOKING; CLINICAL FEATURE; CONVALESCENCE; DIABETES MELLITUS; DISEASE PREDISPOSITION; EMBOLISM; FAMILY HISTORY; GENETIC PREDISPOSITION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; ORAL CONTRACEPTION; PHYSICAL ACTIVITY; PROGNOSIS; REVIEW; RISK FACTOR; STROKE; TRANSIENT ISCHEMIC ATTACK; TRANSITIONAL BLINDNESS;

AGE FACTORS; BRAIN; CAROTID ARTERY DISEASES; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR CIRCULATION; COLLATERAL CIRCULATION; CONTRACEPTIVES, ORAL; DIET; FEMALE; HUMANS; MALE; OBESITY; RISK FACTORS; SEX FACTORS; SMOKING;

EID: 0033763562     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/000331970005101001     Document Type: Review

References (181)

1. The Stroke Data Bank: Design, methods, and baseline characteristics
2. Incidence of stroke in Oxfordshire: First year's experience of a community stroke register
3. Stroke in South Alabama: Incidence and diagnostic features - A population-based study
4. Incidence of stroke in the Finnish Prospective Population Study
5. Stroke incidence and risk factors for stroke in Copenhagen, Denmark
6. First-year resuits of a community-based study of stroke incidence in Umbria, Italy
7. Incidence and prognosis of stroke in the Belluno Province, Italy
8. The frequency, causes, and timing of death within 30 days of a first stroke: The Oxfordshire Community Stroke Project
9. Computed tomography of cerebral infarction: Hemorrhagic, contrast enhancement, and time of appearance
10. Special report from the National Institute of the Neurological Disorders and Stroke: Classification of Cerebrovascular Disease III
11. American Heart Association Prevention Conference. IV. Prevention and rehabilitation of stroke. Risk factors
12. Familial aggregation of stroke. The Framingham Study
13. Primary prevention of stroke
14. Prevention of stroke
15. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: Overview of randomised drug trials in their epidemiological context
16. Mortality associated with diastolic hypertension and isolated systolic hypertension among men screened for the Multiple Risk Factor Intervention Trial
17. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group
18. Meta-analysis of relation between cigarette smoking and stroke
19. Risk of stroke in male cigarette smokers
20. Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial
21. For the Cholesterol and Recurrent Events Trial Investigators. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
22. Design features and baseline characteristics of the LIPID (Long-Term Intervention with Pravastatin in Ischemic Disease) Study: A randomized trial in patients with previous acute myocardial infarction and/or unstable angina pectoris
23. Statins do more than just lower cholesterol
24. Antiatherothrombotic properties of statins: Implications for cardiovascular event reduction
25. A prospective investigation of elevated lipoprotein (a) detected by electrophoresis and cardiovascular disease in women. The Framingham Heart Study
26. Lipids and stroke: A paradox resolved
27. Body height, cardiovascular risk factors, and risk of stroke in middle-aged men and women. A 14-year follow-up of the Finnmark Study
28. Glucose intolerance and 22-year stroke incidence. The Honolulu Heart Program
29. Nonfasting serum glucose and insulin concentrations and the risk of stroke
30. Proteinuria is an independent risk factor for ischemic stroke in non-insulin-dependent diabetes mellitus
31. Role of insulin resistance associated with compensatory hyperinsulinemia in ischemic stroke
32. Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators
33. Body weight and coronary heart disease mortality: An analysis in relation to age and smoking habit. 15 Years follow-up data from the Whitehall Study
34. Fibrinogen as a risk factor for stroke and myocardial infarction
35. Fibrinogen and viscosity as risk factors for subsequent cardiovascular events in stroke survivors
36. Cerebrovascular and neurologic disease associated with antiphospholipid antibodies: 48 Cases
37. Free protein S deficiency: A possible association with cerebrovascular occlusion
38. Accelerated brain infarction in hypertension complicated by hereditary heterozygous protein C deficiency
39. Congenitally abnormal plasminogen in juvenile ischemic cerebrovascular disease
40. Ischemic stroke in young patients with activated protein C resistance. A report of three cases belonging to three different kindreds
41. Prevalence of factor V Leiden mutation in young adults with cerebral ischemia: A case-control study on 225 patients
42. Tissue plasminogen activator and plasminogen activator inhibitor in patients with acute ischemic stroke: Relation to stroke etiology
43. Elevated tissue plasminogen activator antigen and stroke risk: The Stroke Prevention In Young Women Study
44. Tissue plasminogen activator, plasminogen activator inhibitor-1, and tissue plasminogen activator/plasminogen activator inhibitor-1 complex as risk factors for the development of a first stroke
45. Oral contraceptives and cardiovascular disease (first of two parts)
46. Oral contraception and stroke. Evidence from the Royal College of General Practitioners' Oral Contraception Study
47. Hemoglobin and the risk of cerebral infarction: The Framingham Study
48. Importance of the hematocrit as a risk factor in cerebral infarction
49. Hematocrit as a risk factor of cerebral infarction: Long-term prospective population survey in a Japanese rural community
50. Vascular event rates in patients with atherosclerotic cerebrovascular disease
51. The natural history of amaurosis fugax
52. The risk of stroke in patients with first ever retinal vs hemispheric transient ischemic attacks and highgrade carotid stenosis
53. Subtypes of transient monocular blindness and subsequent risk of vascular complications
54. Mortality and stroke after amaurosis fugax
55. Comparison of amaurosis fugax and transient cerebral ischemia: A prospective clinical and arteriographic study
56. Transient ischemic attacks and risk of stroke in an elderly poor population
57. Prognosis in patients with transient ischemic attacks
58. Control trial of aspirin in cerebral ischemia
59. Increasing incidence of stroke among Swedish women
60. Prognosis in patients with transient ischemic attacks
61. Transient cerebral ischemia. Prevalence and prognosis in a biracial rural community
62. Transient ischemic attacks due to atherosclerosis
63. Prognosis of transient ischemic attacks in the Oxfordshire Community Stroke Project
64. The prognosis of hospital-referred transient ischemic attacks
65. Long term prognosis of transient cerebral ischemic attacks
66. Carotid and vertebral-basilar transient cerebral ischemic attacks
67. Determinants of early recurrence of cerebral infarction: The Stroke Data Bank
68. Ischemic stroke events and carotid atherosclerosis: Results of the Osaka follow-up study for ultrasonographic assessment of carotid atherosclerosis (the OSACA Study)
69. A secondary prevention: Randomized trial of suloctidil in patients with a recent history of thromboembolic stroke
70. High-dose acetylsalicylic acid after cerebral infarction: A Swedish cooperative study
71. Stroke recurrence within two years after ischemic infarction
72. Long-term risk of recurrent stroke after a first-ever stroke: The Oxfordshire Community Stroke Project
73. Natural history of stroke in Rochester, Minnesota: 1955 through 1969: An extension of the previous study: 1945 through 1954
74. Natural history of stroke in Rochester, Minnesota, 1945 through 1954
75. Neurosyphilis
76. Neurological complications of acquired immune deficiency syndrome: Analysis of 50 patients
77. Physical activity and stroke incidence in women and men. The NHANES I Epidemiologic Follow-up Study
78. INTERSALT study findings. Public health and medical care implications
79. Does consumption of fruit and vegetables protect against stroke?
80. Dietary potassium and stroke-associated mortality. A 12-year prospective population study
81. Stroke and alcohol consumption
82. Alcohol intake and the risk of cardiovascular disease in middle-aged Japanese men
83. Stroke associated with cocaine use
84. Current concepts of cerebrovascular disease - Stroke: Stroke and drug abuse
85. Mendelian etiologies of stroke
86. Evaluation of genetic risk factors for silent brain infarction
87. Lipoprotein and apolipoprotein profile in men with ischemic stroke. Role of lipoprotein (a), triglyceride-rich lipoproteins, and apolipoprotein E polymorphism
88. The apolipoprotein E and beta-fibrinogen G/A-455 gene polymorphisms are associated with ischemic stroke involving large-vessel disease
89. Apolipoprotein E epsilon 2 allele and risk of stroke in the older population
90. Plasminogen activator inhibitor-1 (PAI-1) 4G/5G promoter polymorphism and levels in subjects with cerebrovascular disease
91. Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study
92. Diagnostic accuracy of computerized B-scan texture analysis and conventional ultrasonography in diffuse parenchymal and malignant liver disease
93. Consensus concerning the morphology and the risk of carotid plaques
94. Duplex ultrasonography and selection of patients for carotid endarterectomy: Plaque morphology or luminal narrowing
95. Sonographic evaluation of carotid artery atherosclerosis in the elderly: Relationship of disease severity to stroke and transient ischemic attack
96. Carotid artery atheroma: Comparison of preoperative B-mode ultrasound appearance with carotid endarterectomy specimen pathology
97. The spectrum of carotid artery disease in asymptomatic patients
98. Carotid artery atheroma: Ultrasound appearance in symptomatic and asymptomatic vessels
99. Characterisation of symptomatic and asymptomatic carotid plaques using high-resolution real-time ultrasonography
100. Symptoms, stenosis and carotid plaque morphology. Is plaque morphology relevant
101. The identification of high risk carotid plaque
102. Natural history of asymptomatic carotid plaque
103. The role of plaque morphology and diameter reduction in the development of new symptoms in asymptomatic carotid arteries
104. The natural history of asymptomatic carotid artery disease
105. Ultrasonic classification of carotid plaques causing less than 60% stenosis according to the ultrasound morphology and events
106. Hypo-echoic plaque on US of the carotid artery: An independent risk factor for incident stroke in adults 65 years or older
107. Ultrasonographic features of carotid plaque and the risk of subsequent neurologic deficits
108. Carotid plaque histology using a real-time ultrasonography
109. Tissue characterization of atheromatous plaques: Correlation between ultrasound image and histological findings
110. Carotid plaque characteristics and presenting symptom
111. Clinico-pathologic study of carotid endarterectomy plaques
112. Carotid intraplaque hemorrhage: The significance of neovascularity
113. Importance of ulceration of carotid plaque in determining symptoms of cerebral ischemia
114. Carotid plaque morphology correlates with presenting symptomatology
115. Vascular risks of asymptomatic carotid stenosis
116. Prognosis for patients following a transient ischemic attack with and without a cerebral infarction on brain CT
117. North American Symptomatic Carotid Endarterectomy Trial Collaborators: Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis
118. Four-dimensional ultrasonographic characterization of plaque surface motion in patients with symptomatic and asymptomatic carotid artery stenosis
119. The carotid bifurcation plaque: Pathologic findings associated with cerebral ischemia
120. Carotid plaque hemorrhage
121. The natural history of carotid plaque development
122. The importance of hemorrhage in the relationship between gross morphologic characteristics and cerebral symptoms in 376 carotid artery plaques
123. Intraplaque hemorrhage: Its significance in cerebrovascular disease
124. Correlation of B-mode ultrasound imaging and arteriography with pathologic findings at carotid endarterectomy
125. Intraplaque hemorrhage
126. The influence of repeated carotid plaque hemorrhages on the production of cerebrovascular symptoms
127. Prospective clinicopathologic study of carotid plaque hemorrhage
128. Histologic characteristics of carotid artery plaque
129. Carotid endarterectomy plaques: Correlations of clinical and anatomic findings
130. Lack of association between carotid plaque hematoma and ischemic cerebral symptoms
131. Critical carotid stenosis: Morphologic and chemical similarity between symptomatic and asymptomatic plaques
132. Hemorrhagic carotid plaque does not contain hemorrhage
133. Clinical prevalence of intraplaque hemorrhage in the internal carotid artery
134. Carotid plaque morphology and clinical events
135. Juxtaluminal location of plaque necrosis and neoformation in symptomatic carotid stenosis
136. The relationship between carotid plaque composition, plaque morphology, and neurologic symptoms
137. Cervical manipulation and stroke
138. Symp tomatic carotid artery occlusion. A reappraisal of hemodynamic factors
139. A new aspect of collateral circulation in occlusion of internal carotid artery
140. The risks and benefits of carotid endarterectomy in patients with near occlusion of the carotid artery. North American Symptomatic Carotid Endarterectomy Trial (NASCET) Group
141. Cerebral blood flow reserve assessment in symptomatic versus asymptomatic high-grade internal carotid artery stenosis
142. Assessment of cerebral vasomotor reactivity by transcranial Doppler ultrasound and breath holding
143. Transcranial Doppler assessment of cerebrovascular reactivity in symptomatic and asymptomatic severe carotid stenosis
144. Does carotid endarterectomy modify cerebral vasomotor reactivity?
145. Acetazolamide SPECT scans in the evaluation of symptomatic and asymptomatic patients with carotid occlusive disease
146. Collateral cerebral vascular resistance in patients with significant carotid stenosis
147. 2 vasomotor response in normal individuals and patients with internal carotid artery occlusions
148. Vasomotor reactivity and pattern of collateral blood flow in severe occlusive carotid artery disease
149. Increased oxygen extraction fraction is associated with prior ischemic events in patients with carotid occlusion
150. Evidence of misery perfusion and risk for recurrent stroke in major cerebral arterial occlusive disease from PET
151. Is impaired cerebral vasomotor reactivity a predictive factor of stroke in asymptomatic patients?
152. Course of carotid artery occlusions with impaired cerebrovascular reactivity
153. Increased stroke risk predicted by compromised cerebral blood flow reactivity
154. Compromised cerebral blood flow reactivity is a predictor of stroke in patients with symptomatic carotid occlusive disease
155. Outcome of carotid artery occlusion is predicted by cerebrovascular reactivity
156. Influence of cerebral hemodynamics on stroke risk: One year follow-up of 30 medically treated patients
157. Effect of acetazolamide reactivity and long-term outcome in patients with major cerebral artery occlusive diseases
158. Sequential change of hemodynamic reserve in patients with major cerebral artery occlusion or severe stenosis
159. Long-term changes in cerebral blood flow according to different types of ischemic stroke
160. Regional cerebral blood flow and its autoregulation in patients with focal cerebral ischemic attacks
161. Regional cerebral blood flow in apoplexy without arterial occlusion
162. Reactivity of cerebral circulation in patients with carotid occlusion
163. Subacute and chronic cerebral infarctions: SPECT and gadolinium-DTPA enhanced MR imaging
164. 2 test to exclude patients not in need of extracranial/intracranial bypass surgery
165. Course of cerebrovascular reactivity in patients with carotid artery occlusions
166. 2 responsiveness as an indicator of collateral reserve capacity in patients with carotid arterial disease
167. Cerebrovascular reactivity to acetazo lamide in carotid artery disease
168. Effect of the internal carotid artery occlusion on intracranial hemodynamics
169. Transcranial Doppler in the management of extracranial cerebrovascular disease: Implications in the diagnosis and monitoring
170. Prevalence of impaired cerebrovascular reserve in patients with symptomatic carotid artery disease
171. The effect of hemodynamic significant carotid artery disease on the hemodynamic status of the cerebral circulation
172. Blood flow reactivity to hypercapnia in strictly unilateral carotid disease: Preliminary results
173. Evaluation of cerebral perfusion reserve in patients with carotid artery occlusion
174. Intracerebral hemorrhage revisited
175. Hematologic causes of intracerebral hemorrhage and their treatment
176. Cerebral amyloid angiopathy. A critical review
177. Emergence of recreational drug abuse as a major risk factor for stroke in young adults
178. MR imaging as predictor of delayed posttraumatic cerebral hemorrhage
179. Spontaneous intracranial hemorrhage caused by brain tumor: Its incidence and clinical significance
180. Hemorrhagic stroke due to cerebral vasculitis and the role of immunosuppressive therapy